Effects of suramin on anastomotic colon tumors in a rat model

European Surgical Research

Volumn 31, Issue 4, 1999, Pages 347-356

  Lauwers, P ^a   Hubens, Guy ^a,c   Hendriks, J ^a   Vermeulen, P ^b   Schuerwegh, A ^a   Stevens, W J ^a   De Clerck, L S ^a   Dirix, L ^b   Van Marck, E ^c   Hubens, A ^a   Eyskens, E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b SINT AUGUSTINUS HOSPITAL   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angiogenesis; Animal study; Colon; Rat; Suramin; Tumor

Indexed keywords

SURAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER TRANSPLANTATION; CARCINOGENESIS; COLON ANASTOMOSIS; COLON TUMOR; CONTROLLED STUDY; ERYTHROCYTE COUNT; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFORMATION TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANASTOMOSIS, SURGICAL; ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; COLON; COLONIC NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; SURAMIN; TUMOR CELLS, CULTURED;

EID: 0032780097     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008712     Document Type: Article

References (24)

1. McNamara DA, Harmey JH, Walsh TN, et al: Significance of angiogenesis in cancer therapy - A review. Br J Surg 1998;85:1044-1055.
2. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
3. La Rocca RV, Stein CA, Myers CE: Suramin: Prototype of a new generation of antitumor compounds. Cancer Cells 1990;2:106-115.
4. Leith JT, Papa G, Quaranto L, et al: Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin. Br J Cancer 1992;66:345-348.
5. Rubio GJ, Pinedo HM, Virizuela J, et al: Effects of suramin on human lung cancer cell lines. Eur J Cancer 1995;31A:244-251.
6. Stein CA: Suramin: A novel antineoplastic agent with multiple potential mechanisms of actions. Cancer Res 1993;53:2239-2248.
7. Falcone A, Pfanner E, Cianci C, et al: Suramin in patients with metastatic colorectal cancer pretreated with fluoromyrimidine-based chemotherapy. Cancer 1995;75:440-443.
8. Frank RE, Saclarides TJ, Leurgans S, et al: Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 1995;222:695-699.
9. Vermeulen PB, Verhoeven D, Fierens H, et al: Microvessel quantification in primary colorectal carcinoma: An immunohistochemical study. Br J Cancer 1995;71:340-343.
10. Vermeulen PB, Verhoeven D, Hubens G, et al: Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol 1995;6:59-64.
11. Hubens G, Willems G: Factors influencing the implantation of colon cancer cells on the colonic suture line in rats. Eur Surg Res 1990;22: 356-364.
12. De Clerq E: Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses. J Cancer Lett 1979;8:9-22.
13. Cole DJ, Ettinghausen SE, Pass HI, et al: Postoperative complications in patients receiving suramin therapy. Surgery 1994;116:90-95.
14. Taylor CW, Lui R, Fanta P, et al: Effects of suramin on in vitro growth of fresh human tumors. J Natl Cancer Inst 1992;84:489-494.
15. Csoka K, Nygren P, Graf W, et al: Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients. Int J Cancer 1995;63:356-360.
16. Morocz IA, Lauber B, Schmitter D, et al: In vitro effect of suramin on lung tumour cells. Eur J Cancer 1993;29A2:245-247.
17. Oliver S, Formento P, Fischel JL, et al: Epidermal growth factor and receptor expression and suramin cytotoxicity in vitro. Eur J Cancer 1992; 26:470-474.
18. Rubio GJ, Pinedo HM, Virizuela J, et al: Effects of suramin on human lung cancer cell lines. Eur J Cancer 1995;31A:244-251.
19. Marquet RL, Westbroek DL, Jeekel J: Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site. Int J Cancer 1984;33:689-692.
20. Eggermont AMM, Marquet RL, De Bruin RWF, et al: Effects of the interferon-inducer ABPP on colon cancer in rats: Importance of tumor load and tumour site. Cancer Immunol Immunother 1986;22:217-220.
21. Lieberman MD, Shou J, Sigal RK, et al: Transfusion-induced immunosuppression results in diminished host survival in a murine neuroblastoma model. J Surg Res 1990;48: 498-503.
22. Toes RE, Offringa R, Blom RJJ, et al: Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc Natl Acad Sci USA 1996;93: 7855-7860.
23. Furusawa E, Furusawa S: Adverse effect of cyclophosphamide at moderate dose in combination with standard drugs on intraperitoneally implanted Lewis lung carcinoma in mice. Chemotherapy 1985;31:216-222.
24. Pierson HF: Enhancement of tumorigenicity of B16 melanoma in heterogenetic mice by administration of copper chelates. Cancer Treat Rep 1985;69:1283-1291.